on a mobile?
 
vTap
    Loading...
 
 
Video
The FDA seized more than 12,000 bottles because the drug raises the risk of optic nerve damage, swelling and eye inflammation. Glen Walker reports.
a year ago
CBS (cbs2 - Los Angeles)
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Optic nerve
Food and Drug Administration
Go to Feed to see what's new!
share
keep
 
 
The label for the diabetes drug must mention an increased risk of heart attack.
a year ago
ABC News
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Food and Drug Administration
Myocardial infarction
Diabetes mellitus
Go to Feed to see what's new!
share
keep
 
 
CNN's Eunice Yoon speaks to U.S. Health Secretary Michael Leavitt about the new FDA offices in China.
2m 5s |
2 days ago
CNN
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Eunice Yoon
Michael Leavitt
Food and Drug Administration
United States
Go to Feed to see what's new!
share
keep
 
 
The average American consumes nearly twice the recommended daily allowance of salt each day. Now the FDA may decide whether to limit the amount of sodium in packaged foods. Nancy Cordes reports.
1m 52s |
11 months ago
CBS News
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Food and Drug Administration
Go to Feed to see what's new!
share
keep
 
 
On Thursday for the first time ever the Food and Drug administration will hold a public meeting to discuss whether to place limits on the amount of sodium in processed foods.
11 months ago
CBS (cbs4 - Denver)
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Food and Drug Administration
Go to Feed to see what's new!
share
keep
 
 
More Videos
 
Keep this video in the "Saved" list
Go to Feed to see what's new!
share
keep
 
 
 
 
Nov. 15 - Millennium Pharmaceuticals' CEO says the U.S. Food and Drug Administration has become "more risk averse" and "patients suffer from the lack of new medicines because of that." Deborah Dunsire, speaking at the Reuters Health Summit in New York on Thursday, says that doing clinical trials outside of the U.S. "has become simpler than it is doing it inside the U.S. because some of the processes and procedures that are followed here." Speaker: Deborah Dunsire CEO, Millennium Pharmaceuticals
5m 33s |
a year ago
Reuters
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Food and Drug Administration
United States
Medical device
United States Department of Health and Human Services
Millennium Pharmaceuticals
Dietary supplement
Biopharmaceutical
Go to Feed to see what's new!
share
keep
 
 

Corporate Home Corporate Home News FAQ About Contact Forums
Privacy Policy and Terms of Use